VBIO (Valion Bio, Inc. Common Stock) Stock Analysis - Analyst Ratings

Valion Bio, Inc. Common Stock (VBIO) is a publicly traded the market company. As of May 21, 2026, VBIO trades at $0.84 with a market cap of $2.70M and a P/E ratio of 0.00. VBIO moved +3.14% today. Year to date, VBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.80 to $1.21. Rallies surfaces VBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate VBIO?

The average price target is $0.00.

VBIO Key Metrics

Key financial metrics for VBIO
MetricValue
Price$0.84
Market Cap$2.70M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$1.21
52-Week Low$0.80
Volume1.56K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

VBIO Analyst Consensus

VBIO analyst coverage data. Average price target: $0.00.

Latest VBIO News

Recent VBIO Insider Trades

  • LoConti Joseph E. bought 1.00K (~$200) on Jul 29, 2021.
  • LoConti Joseph E. bought 13.00K (~$2.60K) on Jul 20, 2021.
  • LoConti Joseph E. bought 40.00K (~$6.40K) on Jul 19, 2021.

Common questions about VBIO

What do analysts rate VBIO?
The average price target is $0.00.
Does Rallies show VBIO price targets?
Yes. Rallies tracks VBIO analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is VBIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VBIO. It does not provide personalized investment advice.
VBIO

VBIO